The U.S., Costa Rica, El Salvador, Guatemala, Honduras and Nicaragua signed the U.S.-Central American Free Trade Agreement ("CAFTA") last week. The agreement would extend patent rights for pharmaceuticals in the Central American countries.

« Revision of Power of Attorney and Assignment Practice | Main | Patent Video »
Jason Rantanen,
Associate Professor
University of Iowa
College of Law
SSRN Articles
Occasional guest posts by IP practitioners and academics
Recent Comments